Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing
Reexamination Certificate
2007-04-24
2007-04-24
Chism, B. Dell (Department: 1654)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
C424S009351
Reexamination Certificate
active
11294625
ABSTRACT:
Imaging agents for magnetic resonance imaging are disclosed. Methods of monitoring angiogenesis and the growth and remission of tumor tissue are also disclosed. Methods of monitoring blood clot formation and dissolution are additionally disclosed. Methods of monitoring wound healing are further disclosed. A kit for obtaining an image of a biological structure is further disclosed.
REFERENCES:
patent: WO 91/01144 (1991-02-01), None
patent: WO 89/00051 (1989-01-01), None
patent: WO 99/60018 (1999-11-01), None
patent: WO 9960018 (1999-11-01), None
patent: WO 99/61072 (1999-12-01), None
patent: WO 03/006070 (2003-01-01), None
European Office Action dated May 9, 2006.
Dewhirst Mark W.
Greenberg Charles S.
Haroon Zishan
Neeman Michal
Chism B. Dell
Duke University
Jenkins Wilson Taylor & Hunt, P.A.
Yeda Research and Development Co. Ltd.
LandOfFree
Contrast enhancement agent for magnetic resonance imaging does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Contrast enhancement agent for magnetic resonance imaging, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Contrast enhancement agent for magnetic resonance imaging will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3771600